A carregar...
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
OBJECTIVE: Despite multiple drugs available, a large proportion of patients with generalized anxiety disorder (GAD) do not show adequate response and remission. Thus, additional novel pharmacological agents are needed to increase treatment option for GAD. We aimed to investigate efficacy and safety...
Na minha lista:
| Publicado no: | Clin Psychopharmacol Neurosci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean College of Neuropsychopharmacology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383014/ https://ncbi.nlm.nih.gov/pubmed/32702221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.3.423 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|